Drugs / CBT-009
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05372991 | Jul 2022 → Jan 2023 | myopia | Cloudbreak Therapeutics, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBT-009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05372991 ↗ |
| Route | Other | “CBT-009 eye drop” NCT05372991 ↗ |